Henke Erik, Nandigama Rajender, Ergün Süleyman
Department of Medicine, Institute of Anatomy and Cell Biology, Universität Würzburg, Würzburg, Germany.
Front Mol Biosci. 2020 Jan 31;6:160. doi: 10.3389/fmolb.2019.00160. eCollection 2019.
Solid tumors are complex organ-like structures that consist not only of tumor cells but also of vasculature, extracellular matrix (ECM), stromal, and immune cells. Often, this tumor microenvironment (TME) comprises the larger part of the overall tumor mass. Like the other components of the TME, the ECM in solid tumors differs significantly from that in normal organs. Intratumoral signaling, transport mechanisms, metabolisms, oxygenation, and immunogenicity are strongly affected if not controlled by the ECM. Exerting this regulatory control, the ECM does not only influence malignancy and growth of the tumor but also its response toward therapy. Understanding the particularities of the ECM in solid tumor is necessary to develop approaches to interfere with its negative effect. In this review, we will also highlight the current understanding of the physical, cellular, and molecular mechanisms by which the pathological tumor ECM affects the efficiency of radio-, chemo-, and immunotherapy. Finally, we will discuss the various strategies to target and modify the tumor ECM and how they could be utilized to improve response to therapy.
实体瘤是复杂的器官样结构,不仅由肿瘤细胞组成,还包括脉管系统、细胞外基质(ECM)、基质细胞和免疫细胞。通常,这种肿瘤微环境(TME)占整个肿瘤质量的较大部分。与TME的其他成分一样,实体瘤中的ECM与正常器官中的ECM有显著差异。如果不受ECM控制,瘤内信号传导、转运机制、代谢、氧合和免疫原性会受到强烈影响。ECM发挥这种调节控制作用,不仅影响肿瘤的恶性程度和生长,还影响其对治疗的反应。了解实体瘤中ECM的特殊性对于开发干预其负面影响的方法至关重要。在本综述中,我们还将强调对病理性肿瘤ECM影响放疗、化疗和免疫治疗效果的物理、细胞和分子机制的当前理解。最后,我们将讨论靶向和修饰肿瘤ECM的各种策略,以及如何利用这些策略来改善治疗反应。